Hill Sara
Known title: CHROCIK: 0002036817
Associated companies
Transaction History
| CVSA | ▲ Buy | Grant | 1,673 | $162K | 11/12/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 1,310 | $195K | 10/15/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 2,226 | $300K | 8/23/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 1,003 | $135K | 8/23/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 8,690 | $650K | 10/15/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Covista receives mixed analyst coverage and rating update
Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.
Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.